NeurologyLive® Friday 5 — September 19, 2025

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Evolving Responsibilities of Vice Chairs in Neurology Leadership: Mud Alvi, MD

The vice chair of neurology at West Virginia University outlined key challenges in academic neurology and reflected on the evolving responsibilities of vice chairs in supporting departmental growth and leadership. [WATCH TIME: 3 minutes]

2: Optimizing Speech and Movement Therapy to Improve Motor and Nonmotor Symptoms of Parkinson Disease: Cynthia Fox, PhD, CCC-SLP

The CEO and co-founder of LSVT Global talked about how evidence-based therapies like LSVT LOUD and LSVT BIG can improve speech and movement in patients with Parkinson disease. [WATCH TIME: 5 minutes]

3: Recognizing Macromastia in Women as a Potential Risk Factor for Headache: Kristyn Pocock, MD

At AHS 2025, the assistant professor of neurology at Wake Forest Baptist Atrium Health discussed clinical interventions for women with enlarged breast who experience headache. [WATCH TIME: 4 minutes]

4: NeuroVoices: Danielle Andrade, MD, MSc, FRCPC, on Guiding College Students With Epilepsy Through Transition of Care

In our latest NeuroVoices Q&A, the director of the Adult Genetic Epilepsy Program at the University of Toronto shared “back-to-school” guidance on best practices in helping young patients with epilepsy transition to adult care.

5: 10 Years of the Women Neurologists Group: A Preview of the 4th Annual Conference

In this latest Roundtable Discussion, movement disorder specialists reflected on the community’s growth over the past decade in the Women’s Neurology Group and shared program highlights of the group’s upcoming conference. [WATCH TIME: 5 minutes]